Clusters of SARS-CoV-2 Lineage B.1.1.7 Infection after Vaccination with Adenovirus-Vectored and Inactivated Vaccines.
Adenoviridae
Adult
Aged
Aged, 80 and over
Antibodies, Neutralizing
/ immunology
Brazil
/ epidemiology
COVID-19
/ immunology
COVID-19 Serological Testing
COVID-19 Vaccines
Cohort Studies
Disease Outbreaks
/ statistics & numerical data
Female
Genetic Vectors
Humans
Immunoglobulin G
/ blood
Male
Middle Aged
RNA, Viral
SARS-CoV-2
/ classification
Vaccination
Vaccines, Inactivated
Whole Genome Sequencing
Young Adult
B.1.1.7
COVID-19
SARS-CoV-2
outbreak
vaccine
variant of concern
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
22 10 2021
22 10 2021
Historique:
received:
11
09
2021
revised:
13
10
2021
accepted:
15
10
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
15
12
2021
Statut:
epublish
Résumé
A SARS-CoV-2 B.1.1.7 variant of concern (VOC) has been associated with increased transmissibility, hospitalization, and mortality. This study aimed to explore the factors associated with B.1.1.7 VOC infection in the context of vaccination. On March 2021, we detected SARS-CoV-2 RNA in nasopharyngeal samples from 14 of 22 individuals vaccinated with a single-dose of ChAdOx1 (outbreak A,
Identifiants
pubmed: 34834934
pii: v13112127
doi: 10.3390/v13112127
pmc: PMC8623206
pii:
doi:
Substances chimiques
Antibodies, Neutralizing
0
COVID-19 Vaccines
0
Immunoglobulin G
0
RNA, Viral
0
Vaccines, Inactivated
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council
ID : MC_PC_19012
Pays : United Kingdom
Organisme : NIH HHS
ID : AI120942
Pays : United States
Organisme : Wellcome Trust
ID : 204311/Z/16/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R24 AI120942
Pays : United States
Organisme : Medical Research Council
ID : MR/S019510/1
Pays : United Kingdom
Organisme : São Paulo Research Foundation
ID : 2016/00194-8; 2020/04558-0;2017/13981-0; 2019/24251-9;2018/13645-3, 2018/10224-7, 2020/02159-0, 2017/26908-0; 2018/14389-0
Organisme : National Council for Scientific and Technological Development
ID : 305628/2020-8; 408338/2018-0
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Références
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32381641
Virus Evol. 2015 May 26;1(1):vev003
pubmed: 27774277
Nat Med. 2021 Apr;27(4):620-621
pubmed: 33558724
Cell. 2021 Jul 22;184(15):3962-3980.e17
pubmed: 34171305
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Nat Med. 2021 Apr;27(4):717-726
pubmed: 33664494
JAMA. 2021 Apr 13;325(14):1467-1469
pubmed: 33646292
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Science. 2021 Apr 23;372(6540):363-370
pubmed: 33688062
Lancet Infect Dis. 2021 Nov;21(11):1485-1486
pubmed: 34506735
Lancet Public Health. 2021 May;6(5):e335-e345
pubmed: 33857453
Bioinformatics. 2021 Jul 24;:
pubmed: 34302453
N Engl J Med. 2021 Mar 8;384(15):1466-1468
pubmed: 33684280
Viruses. 2021 May 26;13(6):
pubmed: 34073177
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Virus Evol. 2021 Jul 30;7(2):veab064
pubmed: 34527285
Emerg Infect Dis. 2021 Mar;27(3):970-972
pubmed: 33496249
Lancet Infect Dis. 2021 Aug;21(8):1071-1072
pubmed: 34051887
Lancet Infect Dis. 2020 Jun;20(6):689-696
pubmed: 32220650
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
Lancet Microbe. 2021 Oct;2(10):e527-e535
pubmed: 34258603
Clin Infect Dis. 2021 Apr 07;:
pubmed: 33825859
Cell. 2021 Apr 15;184(8):2201-2211.e7
pubmed: 33743891
Science. 2020 Sep 4;369(6508):1255-1260
pubmed: 32703910
Nat Hum Behav. 2020 Aug;4(8):856-865
pubmed: 32737472
PLoS Biol. 2021 Apr 21;19(4):e3001211
pubmed: 33882066
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Lancet Infect Dis. 2021 Feb;21(2):181-192
pubmed: 33217362
BMJ. 2021 Jan 25;372:n226
pubmed: 33495166
Lancet. 2021 Dec 19;396(10267):1979-1993
pubmed: 33220855
Vaccines (Basel). 2021 Jul 13;9(7):
pubmed: 34358197
Lancet. 2021 Mar 6;397(10277):881-891
pubmed: 33617777
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
BMJ. 2021 May 13;373:n1088
pubmed: 33985964
Wellcome Open Res. 2021 May 19;6:121
pubmed: 34095513
Lancet. 2021 Mar 27;397(10280):1178-1181
pubmed: 33640037
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
J Med Virol. 2021 Oct 1;:
pubmed: 34596904
Lancet Infect Dis. 2020 Jul;20(7):809-815
pubmed: 32330439
Nature. 2021 May;593(7857):136-141
pubmed: 33706364
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Clin Infect Dis. 2021 Aug 19;:
pubmed: 34410361